Ligand Pharmaceuticals (LGND) Operating Income (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ligand Pharmaceuticals | 4.61 Bn | 3.83 Bn | 48.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.46% |
| Dec 31, 2025 | -74.80% |
| Sep 30, 2025 | 550.53% |
| Jun 30, 2025 | 123.32% |
| Mar 31, 2025 | -275.80% |
| Dec 31, 2024 | -406.62% |
| Sep 30, 2024 | 116.46% |
| Jun 30, 2024 | -739.22% |
| Mar 31, 2024 | 188.98% |
| Dec 31, 2023 | -209.10% |
| Sep 30, 2023 | 255.22% |
| Jun 30, 2023 | -113.96% |
| Mar 31, 2023 | 170.68% |
| Dec 31, 2022 | -262.86% |
| Sep 30, 2022 | 42.47% |
| Jun 30, 2022 | 306.09% |
| Mar 31, 2022 | -94.34% |
| Dec 31, 2021 | 139.97% |
| Sep 30, 2021 | -65.66% |
| Jun 30, 2021 | 870.07% |
| Mar 31, 2021 | -79.38% |
| Dec 31, 2020 | 510.22% |
| Sep 30, 2020 | -47.23% |
| Jun 30, 2020 | 87.43% |
| Mar 31, 2020 | 137.21% |
| Dec 31, 2019 | -97.34% |
| Sep 30, 2019 | -24.89% |
| Jun 30, 2019 | -100.50% |
| Mar 31, 2019 | 2,393.42% |
| Dec 31, 2018 | 41.89% |
| Sep 30, 2018 | -66.71% |
| Jun 30, 2018 | 89.45% |
| Mar 31, 2018 | 30.66% |
| Dec 31, 2017 | 71.89% |
| Sep 30, 2017 | 26.72% |
| Jun 30, 2017 | 27.40% |
| Mar 31, 2017 | -47.22% |
| Dec 31, 2016 | 254.10% |
| Sep 30, 2016 | 37.72% |
| Jun 30, 2016 | -73.71% |
| Mar 31, 2016 | 37.04% |
| Dec 31, 2015 | 28.14% |
| Sep 30, 2015 | 96.95% |
| Jun 30, 2015 | 30.34% |
| Mar 31, 2015 | -65.25% |
| Dec 31, 2014 | 172.85% |
| Sep 30, 2014 | 160.09% |
| Jun 30, 2014 | -73.37% |
| Mar 31, 2014 | -20.62% |
| Dec 31, 2013 | 109.28% |
| Sep 30, 2013 | 102.77% |
| Jun 30, 2013 | -61.50% |
| Mar 31, 2013 | -7.98% |
| Dec 31, 2012 | 399.86% |
| Sep 30, 2012 | 21.49% |
| Jun 30, 2012 | -116.33% |
| Mar 31, 2012 | -117.99% |
| Dec 31, 2011 | 243.52% |
| Sep 30, 2011 | -301.11% |
| Jun 30, 2011 | 45.38% |
| Mar 31, 2011 | 75.13% |
| Dec 31, 2010 | 61.96% |
| Sep 30, 2010 | -332.06% |